CLAAD’s policy positions are established through a consensus process, in which at least 80 percent of the participants must represent not-for-profit organizations. This rule of governance ensures that the public interest drives CLAAD’s priorities, as opposed to the interests of individual stakeholders.
New Georgia Law Aims To Control Pill Mills
May 2, 2013 - A law signed by Georgia Gov. Nathan Deal and taking effect July 1 will require pain clinics to be licensed by Georgia’s medical board and owned by physicians. Georgia is the ninth state to require that pain clinics be owned by a physician, according to the National Alliance for Model State Drug Laws. Indiana and Alabama are also considering similar pain-clinic legislation. Full story.
FDA Supports Transition to Safer Medications
April 16, 2013 - CLAAD's executive director, Michael Barnes, issued the following statement today in response to the Food and Drug Administration's decision not to allow generic drug makers to bring crushable OxyContin back to the market: "The Food and Drug Administration's decision to keep non-abuse-deterrent, generic OxyContin off the market will help protect patients, families, and communities from the scourge of prescription drug abuse. We thank the FDA for doing the right thing and urge it to make a similarly smart decision to remove crushable, generic Opana from the market." Full story.